This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. XOMA Royalty's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $. XOMA Royalty's 10-Year median PS Ratio is . Therefore, the Median PS Value for today is $0.00.
As of today (2024-12-14), XOMA Royalty's share price is $25.50. XOMA Royalty's Median PS Value is $0.00. Therefore, XOMA Royalty's Price to Median PS Value for today is 3.12.
The historical rank and industry rank for XOMA Royalty's Median PS Value or its related term are showing as below:
XOMAO.PFD'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.32 Med: 2.39 Max: 10.89
Current: 3.12
During the past 13 years, the highest Price to Median PS Value of XOMA Royalty was 10.89. The lowest was 0.32. And the median was 2.39.
XOMAO.PFD's Price-to-Median-PS-Value is ranked worse than 90.91% of 264
companies
in the Biotechnology industry
Industry Median: 0.7
vs XOMAO.PFD: 3.12
XOMA Royalty Median PS Value Historical Data
The historical data trend for XOMA Royalty's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of XOMA Royalty's Median PS Value
For the Biotechnology subindustry, XOMA Royalty's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XOMA Royalty's Price-to-Median-PS-Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, XOMA Royalty's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where XOMA Royalty's Price-to-Median-PS-Value falls into.
XOMA Royalty Median PS Value Calculation
XOMA Royalty's Median PS Value for today is calculated as
10-Year Median PS Ratio is .
XOMA Royalty's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XOMA Royalty (NAS:XOMAO.PFD) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
XOMA Royalty's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
25.50
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XOMA Royalty Median PS Value Related Terms
Thank you for viewing the detailed overview of XOMA Royalty's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XOMAO.PFD has been successfully added to your 